lysyl-aspartyl-glutamyl-leucine has been researched along with Chronic Disease in 1 studies
*Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matoba, N; Reeves, MA; Royal, JM | 1 |
1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Chronic Disease
| Article | Year |
|---|---|
Repeated Oral Administration of a KDEL-tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis Despite a Robust Immunogenic Response.
Topics: Animals; Cholera Toxin; Chronic Disease; Colitis; Cytokines; Dextran Sulfate; Female; Immunoglobulin A; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Oligopeptides; Protein Sorting Signals; Recombinant Proteins | 2019 |